Evidence map›Paper›PMID 31557256›Full record

Observational studyPloS one2019

Critically ill patients with community-onset intraabdominal infections: Influence of healthcare exposure on resistance rates and mortality.

Emilio Maseda, Sofía Ramírez, Pedro Picatto, Eva Peláez-Peláez, Carlos García-Bernedo, Nazario Ojeda-Betancur, Gerardo Aguilar, Beatriz Forés, Jorge Solera-Marín, María Aliaño-Piña and 7 more

Abstract readComparative StudyMulticenter StudyObservational Study
In one paragraph

Observational study in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Clinical Outcomes of Critically Ill Patients withJournal of fungi (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Secondary infections in mechanically ventilated patients with COVID-19: An overlooked matter?Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Emilio MasedaAnesthesiology and Surgical Critical Care Dpt., Hospital Universitario La Paz, Madrid, Spain.ORCID 0000-0003-2898-7073
Sofía RamírezAnesthesiology and Surgical Critical Care Dpt., Hospital Universitario La Paz, Madrid, Spain.
Pedro PicattoAnesthesiology and Surgical Critical Care Dpt., Hospital Universitario Central de Asturias, Oviedo, Spain.
Eva Peláez-PeláezAnesthesiology and Surgical Critical Care Dpt., Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Carlos García-BernedoAnesthesiology and Surgical Critical Care Dpt., Hospital del Mar, Barcelona, Spain.
Nazario Ojeda-BetancurAnesthesiology and Surgical Critical Care Dpt., Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain.
Gerardo AguilarAnesthesiology and Surgical Critical Care Dpt., Hospital Clínico Universitario, Valencia, Spain.
Beatriz ForésAnesthesiology and Surgical Critical Care Dpt., Hospital Universitario Basurto, Bilbao, Spain.
Jorge Solera-MarínAnesthesiology and Surgical Critical Care Dpt., Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
María Aliaño-PiñaAnesthesiology and Surgical Critical Care Dpt., Hospital Virgen de la Salud, Toledo, Spain.
Eduardo TamayoAnesthesiology and Surgical Critical Care Dpt., Hospital Clínico Universitario, Valladolid, Spain.
Fernando RamascoAnesthesiology and Surgical Critical Care Dpt., Hospital Universitario de la Princesa, Madrid, Spain.
Raquel García-ÁlvarezAnesthesiology and Surgical Critical Care Dpt., Hospital Universitario 12 de Octubre, Madrid, Spain.
Ada González-LisorgeAnesthesiology and Surgical Critical Care Dpt., Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
María-José GiménezPRISM-AG, Madrid, Spain.
Alejandro Suárez-de-la-RicaAnesthesiology and Surgical Critical Care Dpt., Hospital Universitario La Paz, Madrid, Spain.
HELP Investigators and the Perioperative Infection Research Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The concept of healthcare-associated infections (as opposed to hospital-acquired infections) in intraabdominal infections (IAIs) is scarcely supported by data in the literature. The aim of the present study was to analyse community-onset IAIs (non-postoperative/non-nosocomial) in patients admitted to intensive care units (ICUs), to investigate differences in resistance patterns linked to healthcare exposure and mortality-associated factors. A one-year prospective observational study (17 Spanish ICUs) was performed distributing cases as healthcare-associated infections (HCAI), community-acquired infections (CAI) and immunocompromised patients (ICP). Bacteria producing extended-spectrum β-lactamases (ESBL) and/or carbapenemase (CPE), high-level aminoglycoside- and/or methicillin- and/or vancomycin- resistance were considered antimicrobial resistant (AMR). Mortality-associated factors were identified by regression multivariate analysis. Of 345 patients included (18.8% HCAI, 6.1% ICP, 75.1% CAI), 51.6% presented generalized peritonitis; 32.5% were >75 years (55.4% among HCAI). Overall, 11.0% cases presented AMR (7.0% ESBL- and/or CPE), being significantly higher in HCAI (35.4%) vs. CAI (5.8%) (p<0.001) vs. ICP (0%) (p = 0.003). Overall 30-day mortality was 14.5%: 23.1% for HCAI and 11.6% for CAI (p = 0.016). Mortality (R2 = 0.262, p = 0.021) was positively associated with age >75 years (OR = 6.67, 95%CI = 2.56-17.36,p<0.001), Candida isolation (OR = 3.05, 95%CI = 1.18-7.87,p = 0.022), and SAPS II (per-point, OR = 1.08, 95%CI = 1.05-1.11, p<0.001) and negatively with biliary infections (OR = 0.06, 95%CI = 0.01-0.48,p = 0.008). In this study, the antimicrobial susceptibility pattern of bacteria isolated from patients with healthcare contact was shifted to resistance, suggesting the need for consideration of the healthcare category (not including hospital-acquired infections) for severe IAIs. 30-day mortality was positively related with age >75 years, severity and Candida isolation but not with AMR.

Indexed as

Drug Resistance, BacterialAdultAgedAged, 80 and overAge FactorsAnti-Bacterial AgentsBacteriaCommunity-Acquired InfectionsCritical IllnessCross InfectionFemaleHumansIntensive Care UnitsIntraabdominal InfectionsMaleMiddle AgedAnti-Bacterial Agents

Identifiers

PMID31557256
PMCPMC6762167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.